Myron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mHemorrhoidsis a $2BmarketI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokis our leadassetThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAKwas thebest deal Iever madeOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKis our leadassetNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateWe intendto submita BLA in2H 2022We willhaveexclusivityI/ONTAK'spotentialmarket is>$300mOur Halo-Lido trial willhave finalpatient byend of 2022I'm ashareholdermyselfI won't diluteshareholdersWe haveenough cashto go wellinto 2023Mino-WrapWe had aphase 2btrial with100%efficacyMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearInsidersinvested$26.5mHemorrhoidsis a $2BmarketI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokis our leadassetThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAKwas thebest deal Iever madeOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKis our leadassetNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateWe intendto submita BLA in2H 2022We willhaveexclusivityI/ONTAK'spotentialmarket is>$300mOur Halo-Lido trial willhave finalpatient byend of 2022I'm ashareholdermyselfI won't diluteshareholdersWe haveenough cashto go wellinto 2023Mino-WrapWe had aphase 2btrial with100%efficacyMino-Lokpotentialmarket>$1B

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Myron Holubiak and I founded a private company in 2013
  2. We expect to finish the Mino-Lok trial this year
  3. Insiders invested $26.5m
  4. Hemorrhoids is a $2B market
  5. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  6. Mino-Lok is our lead asset
  7. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  8. I/ONTAK was the best deal I ever made
  9. Only biotech with 2 Myron's on the leadership team
  10. I/ONTAK is our lead asset
  11. Not many companies this size with 2 late stage assets
  12. We will open up international sites for Mino-Lok trial
  13. There are no FDA approved drugs to treat hemorrhoids
  14. An actual iMSC update
  15. We intend to submit a BLA in 2H 2022
  16. We will have exclusivity
  17. I/ONTAK's potential market is >$300m
  18. Our Halo-Lido trial will have final patient by end of 2022
  19. I'm a shareholder myself
  20. I won't dilute shareholders
  21. We have enough cash to go well into 2023
  22. Mino-Wrap
  23. We had a phase 2b trial with 100% efficacy
  24. Mino-Lok potential market >$1B